Capsaicin, a fairly simple substituted amide of an aliphatic acid, has long been known as the active principle in hot chili peppers. In addition to causing a pronounced burning sensation, this substance has also been noted to produce a diminished sensitivity to pain. This effect has led a number of investigators to explore the structure–activity relationships of capsaicin in hopes of finding a new drug that would have useful pain-relieving properties without the sting. In recent years the receptor for capsaicin, called TRPV1, has been identified and cloned. This article traces first the development of modified capsaicin structures that offered improved analgesic effectiveness with minimal pungency and then the discovery of compounds that act as antagonists at the TRPV1 receptor. These latter compounds appear to hold promise as new drugs that will be useful for the treatment of some types of pain.
Our Secondary School editors work hard to distill all the JCE materials to produce a fraction of particular interest to high school teachers. We call it CLIC.
In recent years we have worked hard to better match our advertisers with our readers. When shopping for chemistry education materials, visit our advertisers' WWW sites first.
Take JCE along on your outreach missions. Copies of the Journal, guest access to JCE Online, our publications catalog, and more are available for your participants.